Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: Results from Cancer and Leukemia Group B 8461

Sherif S. Farag, Kellie J. Archer, Krzysztof Mrózek, Amy S. Ruppert, Andrew J. Carroll, James W. Vardiman, Mark J. Pettenati, Maria R. Baer, Mazin B. Qumsiyeh, Prasad R. Koduru, Yi Ning, Robert J. Mayer, Richard M. Stone, Richard A. Larson, Clara D. Bloomfield